James L Chen (James Chen)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Metastatic Renal Cell Carcinoma

Electronic Health Record

Top Venues

JCO clinical cancer informatics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

James L Chen, Martin C Stumpe, Ezra Cohen
Evolving From Discrete Molecular Data Integrations to Actionable Molecular Insights Within the Electronic Health Record. JCO clinical cancer informatics 8 (2024)
Islam Eljilany, Payman Ghasemi Saghand, James L Chen, Aakrosh Ratan, Martin D McCarter, John Carpten, Howard Colman, Alexandra P Ikeguchi, Igor Puzanov, Susanne Arnold, Michelle Churchman, Patrick Hwu, Jose Conejo-Garcia, William S Dalton, George J Weiner, Issam El Naqa, Ahmad A Tarhini
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Cancers 15 (20) (2023)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martín-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Richard F Riedel, Silvia Stacchiotti, Elizabeth Trice Loggers, Kristen N Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier García Del Muro Solans, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F Mulcahy, Charles Forscher, Nicolas Penel, Scott H Okuno, Anthony D Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore D F Lapeire, Jean Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K Schwartz, James L Chen, Hari Deshpande, Elizabeth J Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F Meyer, Margaret von Mehren, Brian Andrew Van Tine, Katharina S Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T J Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A Dickson, Dayana Michel, Chang-Ting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R Van Domelen, Christopher J Walker, Hua Chang, Yosef Landesman, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Steven Attia
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Anna E Schorer, Richard Moldwin, Jacob Koskimaki, Elmer V Bernstam, Neeta K Venepalli, Robert S Miller, James L Chen
Chasm Between Cancer Quality Measures and Electronic Health Record Data Quality. JCO clinical cancer informatics 6 (2022)
Jocelyn Y Hsu, Nathan D Seligson, John L Hays, Wayne O Miles, James L Chen
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. JCO precision oncology 6 (2022)
Nathan D Seligson, Joy Tang, Dexter X Jin, Monica P Bennett, Julia A Elvin, Kiley Graim, John L Hays, Sherri Z Millis, Wayne O Miles, James L Chen
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas. NPJ precision oncology 6 (1) (2022)
Sarah Asad, Kathryn Kananen, Kurt R Mueller, William Fraser Symmans, Yujia Wen, Charles M Perou, James S Blachly, James L Chen, Benjamin G Vincent, Daniel G Stover
Challenges and Gaps in Clinical Trial Genomic Data Management. JCO clinical cancer informatics 6 (2022)
Nathan D Seligson, Richard D Maradiaga, Colin M Stets, Howard M Katzenstein, Sherri Z Millis, Alan Rogers, John L Hays, James L Chen
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target. NPJ precision oncology 5 (1) (2021)
N J Speece, Meng Lin Xu, Gabriel Tinoco, David A Liebner, James L Chen
Randomized Prospective Trial Exploring the Impact of Structured Journaling in Patients With Sarcoma on the Management of Treatment-Related Adverse Events. JCO oncology practice (2021)
Andrew Patt, Bryce Demoret, Colin Stets, Kate-Lynn Bill, Philip Smith, Anitha Vijay, Andrew D Patterson, John Hays, Mindy Hoang, James L Chen, Ewy A Math
MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models. Cancers 12 (8) (2020)
Bryce Demoret, Jeff Gregg, David A Liebner, Gabriel Tinoco, Scott Lenobel, James L Chen
Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes. Cancers 11 (12) (2019)
Manojkumar Bupathi, John L Hays, James L Chen
Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series. PloS one 12 (11) (2017)